Caffeine vs Paraxanthine: Which to Choose and for Whom

Is it worth swapping familiar caffeine for more expensive paraxanthine? The editorial team examined for whom the switch may make sense and for whom it is only marketing, and reminded readers of the situations where both substances require caution.

First - what you expect

Paraxanthine appeared on the sports-supplement market recently, and we are increasingly asked the question of whether it is worth switching from caffeine. To answer, one must clearly separate two things: proven effectiveness and promised advantages in tolerability.

The effectiveness of caffeine has been proven by dozens of meta-analyses across various sports. Paraxanthine is mechanistically very similar, so it is logical to expect a comparable stimulating effect, but there is far less direct evidence of improved athletic performance in humans.

The main arguments in favor of paraxanthine concern not the strength of the effect but its "quality": less nervousness, a more predictable action regardless of the genetics of liver enzymes. These arguments are plausible, but definitive conclusions lack independent research.

So our logic is this: caffeine is the default choice; paraxanthine is an option for those who have a specific problem with caffeine and are willing to pay more for an experiment.

Who is better off staying on caffeine

Most athletes.If caffeine suits you well, there are no scientific grounds to switch to more expensive paraxanthine. The 2021 ISSN position recommends 3-6 mg per kilogram of body weight about 60 minutes before exercise, and a lower dose is often enough.

Those watching the budget.Coffee, caffeine tablets or gels with caffeine are cheap and available. Paraxanthine so far costs several times more per serving.

Athletes who undergo doping control.The status of caffeine is transparent: it is not banned and is only on the WADA monitoring program. For new ingredients there is always an additional risk - not so much from the substance itself as from the quality and possible contamination of new products.

Those who love coffee as a ritual.Coffee is also polyphenols and the familiar rhythm of the day. For most people moderate coffee consumption is associated with a neutral or favorable health profile, so there is no need to give it up in favor of capsules.

Who might find paraxanthine interesting

People who tolerate coffee poorly.If even a moderate dose of caffeine causes trembling, anxiety or a racing heart, manufacturers offer paraxanthine as a "milder" alternative. It is worth remembering that Benowitz's 1995 study showed sympathomimetic effects for paraxanthine similar to those of caffeine, so there is no guarantee of mildness. You can try it, but you should start with the minimal dose.

"Slow metabolizers."People with the slow variant of CYP1A2 eliminate caffeine for a long time, and it affects them into the late evening. In theory, taking the ready-made metabolite bypasses part of this variability. In practice a benefit for sleep is not proven, and paraxanthine is also eliminated over hours.

Those who want a more stable effect.Some users report a more even, less "jumpy" stimulating effect. These are subjective reviews, not the results of controlled studies, but for a personal experiment this may be an argument.

• Follow the dose indicated by the manufacturer and do not exceed it.
• Count paraxanthine together with all the caffeine for the day - they act on the same receptors.
• Test in training, not before the start.

Comparison of scenarios

To summarize, we brought typical situations together in a table with the editorial choice.

An interesting nuance concerns smokers. Smoking induces CYP1A2, so caffeine in smokers is eliminated much faster. After quitting smoking, the same amount of coffee may suddenly cause insomnia and nervousness - and the person mistakenly looks for a "milder" alternative, when it is enough to simply reduce the dose.

As for medications: some drugs, in particular fluvoxamine and fluoroquinolone antibiotics, suppress CYP1A2 and sharply slow the elimination of methylxanthines. Since paraxanthine is also metabolized by this enzyme, it is not a "safe workaround."

For pregnant women the EFSA recommendations concern caffeine; for paraxanthine as a separate supplement there are no data, so the editorial team advises abstaining from it.

Mistakes and myths

Myth: paraxanthine is not a stimulant.This is not true: it blocks adenosine receptors, like caffeine, and affects the cardiovascular system. "Mildness" is a marketing characteristic, not a proven property.

Mistake: combining paraxanthine with a large amount of coffee.The effects add up. If you take a capsule of paraxanthine and drink three cups of coffee, the total stimulating load may be excessive.

Myth: paraxanthine is "cleaner" because it has no by-metabolites.It is true that it is not converted into theophylline and theobromine, but these metabolites in moderate amounts are not harmful, and there is no evidence that their absence makes paraxanthine safer.

Mistake: expecting a miracle.Even if paraxanthine suits you better, its effect on athletic performance will most likely be comparable to that of caffeine - that is, small, though useful.

Editorial conclusions

For most people and athletes caffeine remains the rational choice: it is cheap, well studied, and its effectiveness is proven.

Paraxanthine may be the subject of a cautious experiment for those who tolerate coffee poorly or want a more stable action. That said, its advantages so far rest on limited data.

In any case it is worth controlling the total daily dose of stimulants, taking into account sleep, interaction with medications and individual sensitivity.

We also recommend our materials on comparing caffeine with theacrine, on combining caffeine with L-theanine, and on the role of genetics in the response to caffeine.

References

1. Guest NS, VanDusseldorp TA, Nelson MT, et al. International society of sports nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18(1):1.
2. Grgic J, Grgic I, Pickering C, et al. Wake up and smell the coffee: caffeine supplementation and exercise performance — an umbrella review of 21 published meta-analyses. Br J Sports Med. 2020;54(11):681–688.
3. Benowitz NL, Jacob P 3rd, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995;58(6):684–691.
4. Arnaud MJ. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handb Exp Pharmacol. 2011;(200):33–91.
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102.
6. World Anti-Doping Agency. The 2024 Monitoring Program. Montreal: WADA; 2024.